NKX2-5 and diabetic cardiomyopathy: Here we show that the induction of Nkx2.5 downregulation in response to O-GlcNAcylation conditions may be an additional diabetic cardiomyopathy mechanism and possibly interfere with cardiomyocyte survival pathways.